Director/PDMR Shareholding

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Andrew Derodra

2

Reason for Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial Announcement

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Vectura Group plc

b)

LEI

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 0.025 pence each in Vectura Group plc

GB00B01D1K48

b)

Nature of the transaction

Grant of an award under the Company's Long Term Incentive Plan as a nil exercise price option. Vesting is subject to (i) performance over 3 financial years commencing with the year of grant and (ii) continued service and is normally 3 years after grant. Half of the award will vest based on relative total shareholder return (share price growth assuming reinvested dividends) ranking against FTSE250 constituents (excluding financial services and real estate sector companies), 15% vesting at median and 100% at upper quartile. The other half will vest by reference to achievement of cumulative adjusted Earnings Before Interest Tax Depreciation and Amortisation ("EBITDA") targets, 15% vesting at threshold and 100% for achieving stretching performance. At the present time the EBITDA targets are commercially sensitive but will be published shortly after we have updated the market with clarity on the regulatory status of VR315 following the dialogue of ourselves and our partners, Hikma, with the FDA.

c)

Price(s) and volume(s)

d)

Aggregated information

- Aggregated volume

- Price

Not applicable - single transaction

e)

Date of the transaction

25 May 2017

f)

Place of the transaction

Outside a trading venue